XML 52 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Stock-Based Awards (Tables)
12 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Assumptions used to Determine Fair Value of Stock Options Granted to Employees and Directors

The assumptions that the Company used to determine the fair value of the stock options granted to employees and directors were as follows, presented on a weighted average basis:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Risk-free interest rate

 

 

2.46

%

 

 

2.67

%

 

 

2.04

%

Expected term (in years)

 

 

6.12

 

 

 

6.18

 

 

 

6.25

 

Expected volatility

 

 

73.62

%

 

 

72.70

%

 

 

78.60

%

Expected dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity for the year ended December 31, 2019:

 

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

 

 

 

 

Outstanding as of December 31, 2018

 

 

4,414,225

 

 

$

6.79

 

 

 

8.29

 

 

$

2,031

 

Granted

 

 

1,518,500

 

 

 

4.06

 

 

 

 

 

 

 

 

 

Exercised

 

 

(110,156

)

 

 

2.31

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(404,456

)

 

 

6.85

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2019

 

 

5,418,113

 

 

$

6.11

 

 

 

7.69

 

 

$

690

 

Options exercisable at December 31, 2019

 

 

2,919,360

 

 

$

5.54

 

 

 

7.02

 

 

$

665

 

Vested and expected to vest at December 31, 2019

 

 

5,418,113

 

 

$

6.11

 

 

 

7.69

 

 

$

690

 

Summary of Stock-Based Compensation Expense Related to Stock Options, Restricted Stock Awards and ESPP

The Company recorded stock-based compensation expense related to stock options, restricted stock awards, and the ESPP in the following expense categories of its statements of operations and comprehensive loss:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Research and development expenses

 

$

2,350

 

 

$

2,557

 

 

$

1,917

 

General and administrative expenses

 

 

3,641

 

 

 

2,660

 

 

 

2,792

 

 

 

$

5,991

 

 

$

5,217

 

 

$

4,709